These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 17580534

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, Scionti L, Bolli GB.
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Once-daily insulin glargine compared with twice-daily NPH insulin in patients with type 1 diabetes.
    Hershon KS, Blevins TC, Mayo CA, Rosskamp R.
    Endocr Pract; 2004 May; 10(1):10-7. PubMed ID: 15251616
    [Abstract] [Full Text] [Related]

  • 5. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
    Raskin P, Klaff L, Bergenstal R, Hallé JP, Donley D, Mecca T.
    Diabetes Care; 2000 Nov; 23(11):1666-71. PubMed ID: 11092290
    [Abstract] [Full Text] [Related]

  • 6. Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin.
    Porcellati F, Rossetti P, Pampanelli S, Fanelli CG, Torlone E, Scionti L, Perriello G, Bolli GB.
    Diabet Med; 2004 Nov; 21(11):1213-20. PubMed ID: 15498088
    [Abstract] [Full Text] [Related]

  • 7. A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes.
    Home PD, Rosskamp R, Forjanic-Klapproth J, Dressler A, European Insulin Glargine Study Group.
    Diabetes Metab Res Rev; 2005 Nov; 21(6):545-53. PubMed ID: 16021649
    [Abstract] [Full Text] [Related]

  • 8. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.
    Yki-Järvinen H, Dressler A, Ziemen M, HOE 901/300s Study Group.
    Diabetes Care; 2000 Aug; 23(8):1130-6. PubMed ID: 10937510
    [Abstract] [Full Text] [Related]

  • 9. Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.
    Fulcher GR, Gilbert RE, Yue DK.
    Intern Med J; 2005 Sep; 35(9):536-42. PubMed ID: 16105155
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.
    Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA.
    Diabetes Care; 2000 May; 23(5):639-43. PubMed ID: 10834423
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
    Danne T, Philotheou A, Goldman D, Guo X, Ping L, Cali A, Johnston P.
    Pediatr Diabetes; 2013 Dec; 14(8):593-601. PubMed ID: 23730996
    [Abstract] [Full Text] [Related]

  • 13. Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes.
    Bolli GB, Songini M, Trovati M, Del Prato S, Ghirlanda G, Cordera R, Trevisan R, Riccardi G, Noacco C.
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):571-9. PubMed ID: 18676131
    [Abstract] [Full Text] [Related]

  • 14. Insulin glargine: a systematic review of a long-acting insulin analogue.
    Wang F, Carabino JM, Vergara CM.
    Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
    [Abstract] [Full Text] [Related]

  • 15. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery.
    Yeldandi RR, Lurie A, Baldwin D.
    Diabetes Technol Ther; 2006 Dec; 8(6):609-16. PubMed ID: 17109592
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.
    Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
    [Abstract] [Full Text] [Related]

  • 18. Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial.
    Fritsche A, Schweitzer MA, Häring HU, 4001 Study Group.
    Ann Intern Med; 2003 Jun 17; 138(12):952-9. PubMed ID: 12809451
    [Abstract] [Full Text] [Related]

  • 19. Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens.
    Murphy NP, Keane SM, Ong KK, Ford-Adams M, Edge JA, Acerini CL, Dunger DB.
    Diabetes Care; 2003 Mar 17; 26(3):799-804. PubMed ID: 12610040
    [Abstract] [Full Text] [Related]

  • 20. Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.
    McKeage K, Goa KL.
    Treat Endocrinol; 2002 Mar 17; 1(1):55-8. PubMed ID: 15765621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.